Chemoinformaics analysis of 11-Methyl-4-dodecanone
| Molecular Weight | 198.35 | nRot | 9 |
| Heavy Atom Molecular Weight | 172.142 | nRig | 1 |
| Exact Molecular Weight | 198.198 | nRing | 0 |
| Solubility: LogS | -4.027 | nHRing | 0 |
| Solubility: LogP | 4.319 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 39.8486 |
| nHD | 0 | BPOL | 26.9514 |
| QED | 0.503 |
| Synth | 1.933 |
| Natural Product Likeliness | 0.944 |
| NR-PPAR-gamma | 0.832 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.417 |
| Pgp-sub | 0.002 |
| HIA | 0.002 |
| CACO-2 | -4.433 |
| MDCK | 0.0000136 |
| BBB | 0.989 |
| PPB | 0.942093 |
| VDSS | 1.077 |
| FU | 0.0317698 |
| CYP1A2-inh | 0.65 |
| CYP1A2-sub | 0.579 |
| CYP2c19-inh | 0.428 |
| CYP2c19-sub | 0.427 |
| CYP2c9-inh | 0.508 |
| CYP2c9-sub | 0.961 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.137 |
| CYP3a4-inh | 0.077 |
| CYP3a4-sub | 0.119 |
| CL | 8.129 |
| T12 | 0.794 |
| hERG | 0.036 |
| Ames | 0.008 |
| ROA | 0.047 |
| SkinSen | 0.378 |
| Carcinogencity | 0.044 |
| EI | 0.974 |
| Respiratory | 0.627 |
| NR-Aromatase | 0.022 |
| Antiviral | Yes |
| Prediction | 0.754385 |